Crossmark

Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study

Crossref DOI link: https://doi.org/10.1186/s12957-019-1602-z

Published Online: 2019-03-27

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Solaini, Leonardo

D’Acapito, Fabrizio

Passardi, Alessandro

Framarini, Massimo

Tauceri, Francesca

Di Pietrantonio, Daniela

Frassineti, Giovanni Luca

Casadei Gardini, Andrea

Cucchetti, Alessandro

Cavaliere, Davide

Ercolani, Giorgio
License Information

Text and Data Mining valid from 2019-03-27
More Information

Article History

Received: 26 November 2018

Accepted: 18 March 2019

First Online: 27 March 2019

Ethics approval and consent to participate

: This study was approved by the institutional review board; was also conducted in accordance with the Declaration of Helsinki and all patients signed the informed consent.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below